Impact of Payor-Initiated Switching of Inhaled Corticosteroids on Lung Function

To evaluate the impact of a payor-initiated formulary change in inhaled corticosteroid coverage on lung function in patients with asthma and on provider prescribing practices. This formulary change, undertaken in August 2016 by a Medicaid payor in Kentucky, eliminated coverage of beclomethasone dipropionate (BDP), a metered dose inhaler (MDI), in favor of mometasone furoate, available as MDI and dry powder inhaler (DPI).

Source: The Journal of Pediatrics - March 9, 2021 Category: Pediatrics Authors: Scott Bickel, Ronald Morton, Adrian O ’Hagan, Caitlin Canal, Jonathan Sayat, Nemr Eid Tags: Original Articles Source Type: research